fashion -WSS

fashion

author：explore 2025-09-29 01:29:26 - browse：5914

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： STAT Report: Patient voices and perspectives

hotspot

WSS

A new crop of companies is reshaping the health data economy

STAT Report: Patient voices and perspectives

Democrats decry new health bill for going easy on private equity

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

New Alzheimer's drugs heat up race for early detection blood tests

5 important ways Henrietta Lacks changed medical science

focus

fashion

Wikipedia

Affirmative action in medical school literally saved lives

‘Oppenheimer’ and the risks of AI in health care

Peter Hotez and the public health issue of online harassment

Sage hopes for a blockbuster in antidepressant now before FDA

Wildfire smoke exposes gaps in outdoor worker protections

UHS says company favors patients whose insurance pays more

Continuity nursing helped my family in our darkest PICU moments

Roche’s Alnylam deal shows drug firms interested in heart drugs

The high cost of giving birth even with insurance

Physician groups backed by private equity giant lobby on mergers

focus

Why patients can’t get everything they want on drug pricing

UHS says company favors patients whose insurance pays more

New Alzheimer's drugs heat up race for early detection blood tests

Physician groups backed by private equity giant lobby on mergers

A new crop of companies is reshaping the health data economy

Wildfire pollution widens asthma inequities on Long Island

hotspot

hotspot

entertainment

focus